Inventor
Alison CRAWFORD
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
A61BDiagnosis4%
PatentTitleYear
12,570,764Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof202612,344,677Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof202512,091,460Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation202411,633,501Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof202311,485,793Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof202211,453,721Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof202211,254,752Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies202211,155,633Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to REGENERON PHARMA (8)· patent assignee history
2021–2022Patents assigned to REGENERAN PHARMACEUTICALS INC (2)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 8 | 2021–2026 |
| REGENERAN PHARMACEUTICALS INC | 2 | 2021–2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2026 |